High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$11.4M
$11,410,660
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-03-10 | $250,275 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-03-09 | $500,200 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-03-06 | $618,975 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-03-06 | $118,944 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Discretionary Sell
|
2026-02-13 | $100,256 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-01-26 | $67,012 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-01-26 | $436,243 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-01-20 | $184,552 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-01-20 | $215,093 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-01-20 | $109,580 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-01-12 | $476,238 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2026-01-12 | $10,993 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-12-22 | $119,976 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-12-22 | $363,696 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-12-15 | $71,002 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-12-15 | $412,727 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| IRMD |
IRADIMED CORP
|
CFO
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| IRMD |
IRADIMED CORP
|
CFO
Discretionary Sell
|
2025-12-11 | $52,184 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| IRMD |
IRADIMED CORP
|
CFO
Discretionary SellΔOwn -64.7%
|
2025-12-11 | $1,407,158Large | S | Form 4 |
|
IRMD
M
IRADIMED CORP
Chiprin Jeff
• Officer • Chief Commercial Officer
Equity Compensation
2025-12-11
$0
|
||||||
| IRMD |
IRADIMED CORP
|
Officer • Chief Commercial Officer
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-12-01 | $154,762 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-12-01 | $309,032 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-24 | $321,323 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-24 | $80,635 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-24 | $49,857 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Discretionary Sell
|
2025-11-20 | $88,500 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Discretionary Sell
|
2025-11-20 | $88,000 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Discretionary Sell
|
2025-11-20 | $8,828 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Discretionary Sell
|
2025-11-20 | $2,472 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Discretionary Sell
|
2025-11-20 | $8,826 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
Director
Discretionary Sell
|
2025-11-20 | $68,090 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-18 | $156,394 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-18 | $271,563 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-10 | $190,497 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CFO
Discretionary SellΔOwn -81.0%
|
2025-11-10 | $900,162 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-10 | $235,696 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-03 | $135,669 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-03 | $73,539 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-03 | $111,099 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-03 | $8,460 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-03 | $35,600 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-11-03 | $48,849 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-27 | $329,010 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-27 | $54,831 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-27 | $4,589 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-21 | $266,773 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-21 | $107,308 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-13 | $232,860 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-13 | $2,000 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-13 | $128,104 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-06 | $14,454 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-06 | $344,160 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-01 | $77,712 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-01 | $30,472 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-10-01 | $242,774 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-09-23 | $356,290 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-09-17 | $245,240 | S | Form 4 |
| IRMD |
IRADIMED CORP
|
CEO
10b5-1 Sell
|
2025-09-17 | $111,128 | S | Form 4 |